Uzm. Dr. Müge Sönmez
Is this your profile? Claim it and verify your details.
Claim profileTrust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologysaglik.gov.trFrom source
- InstitutionOrdu Devlet Hastanesisaglik.gov.trFrom source
- Publications19 publicationsEurope PMC, OpenAlex, ORCIDFrom source
- ORCID0000-0003-0839-8191ORCIDFrom source
- Last synchronised5 November 2026 09:45https://ordudh.saglik.gov.tr/TR-657253/doktorlarimiz.html#muge-sonmezsaglik.gov.tr
Scientific work
Publications
-
Somatic mutation profiling by NGS-based liquid biopsy in advanced non-small cell lung cancer: frequency, clinical correlates, and prognostic significance
Molecular biology reports, 2026
DOI 10.1007/s11033-026-11971-z PMID 42176127 1 citation (Europe PMC) Open-access full textSource: Europe PMC
-
Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group
BMC Cancer, 2026
DOI 10.1186/s12885-026-16667-y PMID 42693417 Open-access full textSource: OpenAlex
-
Analysis of the results of the BRCA1 and BRCA2 genes in early-onset breast cancer patients from the Ordu province
The Atlantic Journal of Medical Science and Research, 2026
DOI 10.5455/atjmed.2025.11.036 Open-access full textSource: OpenAlex
-
Thiol/Disulfide Homeostasis in Lung Cancer: Insights from a Clinical Study
Antioxidants, 2026
DOI 10.3390/antiox15010114 PMID 41596172 2 citations (Europe PMC) Open-access full textSource: ORCID
-
Calprotectin as a Potential Biomarker for Inflammation in Lung Cancer Patients
Diagnostics, 2026
DOI 10.3390/diagnostics16050780 PMID 41828055 Open-access full textSource: ORCID
-
Evaluating Concordance Between Physicians' Decisions and AI-Generated Treatment Recommendations for Breast Cancer: A Retrospective Pilot Study
Eurasian Journal of Medical Investigation, 2026
DOI 10.14744/ejmi.2612480 Source: ORCID
-
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Scientific Reports, 2025
DOI 10.1038/s41598-025-96157-6 PMID 40188172 8 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Magnesium Depletion Score as a Prognostic Indicator in Endometrial Cancer: A Retrospective Cohort Study
Current Oncology, 2025
DOI 10.3390/curroncol32120695 PMID 41440223 Open-access full textSource: ORCID
-
Evaluation of the Relationship Between Bone Mineral Density and Breast Cancer in Postmenopausal Patients
Middle Black Sea Journal of Health Science, 2025
DOI 10.19127/mbsjohs.1811024 Open-access full textSource: ORCID
-
Second Primary Malignancies in Patients with Solid Tumors: The Prognostic Role of Magnesium Depletion Score
Research Square, 2025
DOI 10.21203/rs.3.rs-7491473/v1 Open-access full textSource: OpenAlex